Drug Ad Warning Letter Rate Jumps; FDA Vows Action To Ensure Compliance
Executive Summary
The number of FDA warning letters for drug promotions rose significantly in 2004, FDA Division of Drug Marketing, Advertising & Communications Director Thomas Abrams said
You may also be interested in...
FDA Ad Division Letter Surge Shows Focus On Prominence Of Risk Information
An upcoming FDA draft guidance on fair balance in promotional materials could benefit manufacturers following a spate of warning letters from the agency's ad division citing the prominence of risk information
FDA Ad Division Letter Surge Shows Focus On Prominence Of Risk Information
An upcoming FDA draft guidance on fair balance in promotional materials could benefit manufacturers following a spate of warning letters from the agency's ad division citing the prominence of risk information
FDA Ad Warning Letters On Track For Significant Increase In 2005
FDA is on track for a significant increase in the number of warning letters issued to drug marketers for advertising violations in 2005